Water soluble phenolics derivatives with dermocosmetic and therapeutic applications
申请人:Libragen
公开号:EP1867729A1
公开(公告)日:2007-12-19
The invention relates to the preparation of phenolics derivatives by enzymatic condensation of phenolics selected among pyrocatechol or its derivatives including (i) protocatechuic acid and its derivatives, (ii) 3,4-dihydroxycinnamic acid with its transisomer or caffeic acid and its derivatives, especially hydrocaffeic acid, rosmarinic acid, chlorogenic acid and caffeic acid phenethyl ester, and with its cis-isomer and its derivatives, especially esculin, (iii) dihydroxyphenylglycol, and (iv) members of the flavonoid familly such as taxifolin and fustin (dihydroflavonols), fisetin (a flavonol), eriodictyol (a flavanone), , with the glucose moiety of sucrose. The production of said phenolics derivatives is achieved with a glucosyltransferase (EC 2.4.1.5) obtained from a culture of Leuconostoc species, and more particularly from the culture of Leuconostoc mesenteroides NRRL B-512F. These O-glucosides of selected phenolics are new, have a solubility in water higher than that of their parent polyphenol and have useful applications in cosmetic and pharmaceutical compositions, such as antioxidative, antiviral, antibacterial, immune-stimulating, antiallergic, antihypertensive, antiischemic, antiarrhytmic, antithrombotic, hypocholesterolemic, antilipoperoxidant, hepatoprotective, anti-inflammatory, anticarcinogenic antimutagenic, antineoplastic, anti-thrombotic, and vasodilatory formulations, or in any other field of application. All the more, glucosylated phenolics derivatives objects of the invention can be hydrolyzed by the human natural microbiotes, thus releasing the active part of the phenolic compound upon time during their usage or by an α-glucosidase (EC 3.2.1.20).
本发明涉及用酶缩合法制备酚类衍生物,所选酚类包括焦儿茶酚或其衍生物,包括(i) 原儿茶酸及其衍生物,(ii) 3,4-二羟基肉桂酸与其反式异构体或咖啡酸及其衍生物,特别是氢咖啡酸、(iii) 二羟基苯甘醇,以及 (iv) 黄酮家族成员,如 taxifolin 和 fustin(二氢黄酮醇)、fisetin(一种黄酮醇)、eriodictyol(一种黄酮),以及蔗糖的葡萄糖分子。上述酚类衍生物的生产是通过一种葡糖基转移酶(EC 2.4.1.5)实现的,该酶是从白色念珠菌(Leuconostoc species)的培养物中获得的,尤其是从中肠白色念珠菌(Leuconostoc mesenteroides NRRL B-512F)的培养物中获得的。抗高血压、抗缺血、抗心律失常、抗血栓、降胆固醇、抗脂过氧化、保肝、抗炎、抗癌、抗突变、抗肿瘤、抗血栓和血管扩张配方,或任何其他应用领域。此外,本发明的葡糖基化酚类衍生物可被人体天然微生物水解,从而在使用过程中或通过α-葡萄糖苷酶(EC 3.2.1.20)释放出酚类化合物的活性部分。